Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

Gang Wang1 Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China;2 China Clinical Research Center for Mental Disorders, Beijing, People’s Republic of China;3 Center of Depression, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China

Yan Cheng4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of ChinaCorrespondence[email protected]

Jia Ning Wang4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of China

Sheng Hu Wu4 Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, People’s Republic of China

Hai Bo Xue5 UCB (Zhuhai) Pharma Co., Ltd., Shanghai, People’s Republic of China

Pages 2077-2087 | Published online: 22 Aug 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

GoldbergJFPerlisRHBowdenCLManic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BDAm J Psychiatry2009166217318119122008
PubMed Web of Science ®Google Scholar
HlastalaSAFrankEMallingerAGThaseMERitenourAMKupferDJBipolar depression: an underestimated treatment challengeDepress Anxiety19975273839262937
PubMedGoogle Scholar
JuddLLAkiskalHSSchettlerPJThe long-term natural history of the weekly symptomatic status of bipolar I disorderArch Gen Psychiatry200259653053712044195
PubMed Web of Science ®Google Scholar
KellerMBLavoriPWCoryellWDifferential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illnessJAMA198625522313831423702024
PubMed Web of Science ®Google Scholar
PostRMThe impact of bipolar depressionJ Clin Psychiatry200566Suppl 551016038596
PubMed Web of Science ®Google Scholar
AltshulerLLGitlinMJMintzJLeightKLFryeMASubsyndromal depression is associated with functional impairment in patients with bipolar disorderJ Clin Psychiatry200263980781112363122
PubMed Web of Science ®Google Scholar
TohenMJacobsTGGrundySLEfficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study GroupArch Gen Psychiatry200057984184910986547
PubMed Web of Science ®Google Scholar
KatagiriHTakitaYTohenMHiguchiTKanbaSTakahashiMSafety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorderCurr Med Res Opin201228570171322356118
PubMed Web of Science ®Google Scholar
TohenMVietaECalabreseJEfficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionArch Gen Psychiatry200360111079108814609883
PubMed Web of Science ®Google Scholar
BenazziFBerkMFryeMAWangWBarracoATohenMOlanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysisJ Clin Psychiatry200970101424143119906346
PubMed Web of Science ®Google Scholar
TohenMKanbaSMcIntyreRSFujikoshiSKatagiriHEfficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed featuresJ Affect Disord2014164576224856554
PubMed Web of Science ®Google Scholar
TohenMKatagiriHFujikoshiSKanbaSEfficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studiesJ Affect Disord20131491–319620123485111
PubMed Web of Science ®Google Scholar
TohenMMcDonnellDPCaseMRandomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depressionBr J Psychiatry2012201537638222918966
PubMed Web of Science ®Google Scholar
KatagiriHTohenMMcDonnellDPEfficacy and safety of olan-zapine for treatment of patients with bipolar depression: Japanese sub-population analysis of a randomized, double-blind, placebo-controlled studyBMC Psychiatry20131313823672672
PubMed Web of Science ®Google Scholar
XueHBLiuLZhangHMontgomeryWTreuerTOlanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature reviewNeuropsychiatr Dis Treat20141084186424876777
PubMed Web of Science ®Google Scholar
MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
PubMed Web of Science ®Google Scholar
SpearingMKPostRMLeverichGSBrandtDNolenWModification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BPPsychiatry Res19977331591719481807
PubMed Web of Science ®Google Scholar
HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
PubMed Web of Science ®Google Scholar
YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
PubMed Web of Science ®Google Scholar
SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859Suppl 2022339881538
PubMed Web of Science ®Google Scholar
TohenMFrankEBowdenCLThe International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersBipolar Disord200911545347319624385
PubMed Web of Science ®Google Scholar
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
PubMed Web of Science ®Google Scholar
American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437Suppl 1S14S8024357209
PubMed Web of Science ®Google Scholar
NiufanGTohenMQiuqingAOlanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trialJ Affect Disord20081051–310110817531327
PubMed Web of Science ®Google Scholar
Eli Lilly and CompanyCDE questions for olanzapine tablets monotherapy bipolar depression NDA Panel Meeting: LY170053 (Olanzapine)Data on file2014
Google Scholar
National Research Council (US) Panel on Handling Missing Data in Clinical TrialsThe Prevention and Treatment of Missing Data in Clinical TrialsWashington (DC)National Academies Press (US)2010
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date